Skip to Main Content

Paper Details

Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.
Circulation
6
2023
HGPS, Hutchinson-Gilford Progeria Syndrome, Hutchinson-Gilford progeria syndrome, Lonafarnib, Patients, Progeria, Progerin, children, lamin A, lonafarnib, lonafarnibpravastatin, participants, patient, plasma, plasma progerin, pravastatin, premature aging disease, progerin, zoledronate
Author NameAffiliation
Ralph B D'AgostinoBoston University
Mark W KieranBoston Children's Hospital and Harvard Medical School
Mark W KieranDana-Farber Cancer Institute, Harvard Medical School
Mark W KieranBoston Children's Hospital and Harvard Medical School
Mark W KieranDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 5

Datasets

Release 1.2